M&A Transactions

SHF Holdings, Inc. completed an acquisition involving Rockview Digital Solutions, Inc. d/b/a Abaca for $30,000,000 of cash and Parent Common Stock (closed 2022-11-15).

“II was renamed Rockview Digital Solutions, Inc., a d/b/a Abaca. Pursuant to the Merger Agreement, the consideration for the transaction provides the Company shareholders with $30,000,000 of cash and Parent Common Stock. The stock consideration consists of 2,100,000 shares of Parent Common Stock at the Closing Date and $12,600,000 (minus the note balance of”

CXJ GROUP CO., Ltd completed an acquisition involving Mr. Rudong Shi for RMB 1 yuan (closed 2022-11-04).

“agreement (the “Agreement”) with Mr. Rudong Shi. Under this agreement, the Company will acquire 100% equity of China company Longkou Xianganfu Trading Co., Ltd. at RMB 1 yuan. After this Agreement comes into force, Longkou Xiang Anfu Trading Co., Ltd. will become a subsidiary of CXJ Group Co., Ltd. . The foregoing description of the Agreement does”

TuSimple Holdings Inc. underwent a change of control involving Mr. Mo Chen for no monetary consideration (closed 2022-11-09).

“As a result, under the SEC's rules with respect to the beneficial ownership of securities, Mr. Chen acquired control of the Company as of November 9, 2022.”

LogicBio Therapeutics, Inc. completed an acquisition involving Alexion Pharmaceuticals, Inc. for $2.07 per Share in cash (closed 2022-11-16).

“waiver of certain other conditions, any and all of the issued and outstanding shares of common stock, par value $0.0001 per share (the “ Shares ”), of the Company at a price of $2.07 per Share, to the seller in cash, without interest (the “ Offer Price ”) , less any applicable withholding taxes, upon the terms and subject to the conditions set forth in the”

Awaysis Capital, Inc. completed an acquisition for $11.4 million (closed 2022-06-30).

“of Agreements of Purchase and Sale, all dated April 15, 2022. The total consideration paid by us for the properties subject to the agreements was at the appraisal value of $11.4 million (excluding transaction costs and fees) and was settled in a combination of a Purchase Money Mortgage of $2.6 million at 0% interest rate, payable on demand, a Purchase Money”

East Stone Acquisition Corp underwent a change of control involving NWTN Inc. (Pubco) for Pubco Class B ordinary shares and warrants issued to East Stone securityholders; ICONIQ shareholders received Pubco shares (closed 2022-11-11).

“On November 11, 2022 (the “Closing Date”), as contemplated by the Business Combination Agreement, First Merger Sub merged with and into ICONIQ, with ICONIQ surviving the First Merger as a wholly-owned subsidiary of Pubco. Immediately following the First Merger, the Second Merger Sub merged with and into East Stone, with East Stone surviving the Second Merger as a wholly-owned subsidiary of the Pubco.”

Golden Developing Solutions, Inc. completed an acquisition involving Bushnell Pharmacy LLC for $2,250,000, which included inventory of $550,000, RX Data of $1,690,000 and member's non-compete contribution of $10,000 (closed 2022-11-09).

“As previously announced, on October 4, 2022, the Company entered into a second Asset Purchase and Sale Agreement (the “APA Two”) with Bushnell Pharmacy LLC, a Florida limited liability company (“Seller Two”), pursuant to which the Company was to purchase certain assets currently utilized in the operation of Seller Two’s pharmacy located at 1304 Golden Gate Drive, Southlake, TX 76092. The purchase price under the APA Two was $2,250,000, which included inventory of $550,000, RX Data of $1,690,000 and member’s non-compete contribution of $10,000. Closing was not conditioned on the completion of the any due diligence. On November 9, 2022, the Company completed the acquisition of the assets from Seller Two pursuant to the terms of APA Two.”

Golden Developing Solutions, Inc. completed an acquisition involving Sai Siva Healthcare, LLC for $3,050,000, which included inventory of $650,000, RX Data of $2,390,000 and member's non-compete contribution of $10,000 (closed 2022-11-09).

“As previously announced, on October 4, 2022, Golden Developing Solutions, Inc., a Nevada corporation (“we”, “us” or the “Company”) entered into an Asset Purchase and Sale Agreement (the “APA One”) with Sai Siva Healthcare, LLC, a Florida limited liability company (“Seller”), pursuant to which the Company was to purchase certain assets currently utilized in the operation of Seller’s pharmacy located at 12753 S.W. 42 nd St., Miami, FL 33175. The purchase price under the APA One was $3,050,000, which included inventory of $650,000, RX Data of $2,390,000 and member’s non-compete contribution of $10,000. Closing was not conditioned on the completion of the any due diligence. On November 9, 2022, the Company completed the acquisition of the assets from Seller pursuant to the terms of APA One.”

Fintech Scion Ltd completed an acquisition involving all of the shareholders of HWGG Capital (closed 2022-11-15).

“On November 15, 2022, HWGC Holdings Limited, a Nevada corporation (the “ Company ”), consummated the share exchange transaction (the “ Share Exchange ”) contemplated by the Share Exchange Agreement, dated July 21, 2022 (the “ Share Exchange Agreement ”), by and among the Company, HWGG Capital P.L.C., a Labuan company (“ HWGG Capital ”), and all of the shareholders of HWGG Capital (the “ HWGG Shareholders ”). Pursuant to the terms and provisions of the Share Exchange Agreement, effective as of the closing (the “ Effective Time ”), the Company acquired all of the issued and outstanding ordinary shares of HWGG Capital (the “ HWGG Shares ”) from the HWGG Shareholders in exchange for an aggregate of 91,666,667 shares of common stock of the Company (the “ Exchange Shares ”), with each HWGG Shareholder receiving a pro rata portion of the Exchange Shares based upon the total number of HWGG Shares held by such HWGG Shareholder immediately prior to the Effective Time. As a result of the Share Ex”

CHANNELADVISOR CORP underwent a change of control involving CommerceHub, Inc. for $23.10 in cash (closed 2022-11-15).

“of the Effective Time, had neither effectively withdrawn nor lost their rights to such appraisal and payment under the DGCL) was canceled and converted into the right to receive $23.10 in cash, without interest thereon (the “Merger Consideration”), subject to any withholding of taxes required by applicable law; (ii) option to purchase Shares (each, a “Company”

Altus Power, Inc. completed an acquisition involving D.E. Shaw Renewables Investments, L.L.C. for approximately an aggregate of $201 million base purchase price.

“Agreements”) related to this transaction, and others, was originally announced on September 27, 2022. The purchase price for these assets is approximately an aggregate of $201 million base purchase price of which the Company paid an aggregate of $82 million in cash at closing and held back an aggregate $20 million as security for indemnification claims which”

CareMax, Inc. completed an acquisition involving Sparta Holding Co. LLC for $25.0 million in cash and 23,500,000 shares of Class A common stock (closed 2022-11-10).

“of the Company. The aggregate consideration paid to the Seller under the Merger Agreement at the closing of the Transactions (the “Closing”) consisted of (i) a cash payment of $25.0 million, subject to customary adjustments, and (ii) 23,500,000 shares (the “Initial Share Consideration”), subject to adjustment, of the Company’s Class A common stock, par value $0.0001”

Stonemor Inc. underwent a change of control involving Axar Cemetery Parent Corp. (closed 2022-11-01).

“StoneMor Inc. (the “Company”) is filing this Amendment No. 1 on Form 8-K (this “Amendment”) to amend the Company’s Current Report on Form 8-K, originally filed with the U.S. Securities and Exchange Commission on November 3, 2022 in connection with the consummation of the merger (the “Merger”) contemplated by the Agreement and Plan of Merger dated as of May 24, 2022, by and among the Company, Axar Cemetery Parent Corp. (“Parent”), a Delaware corporation and an indirect wholly-owned subsidiary of Axar Capital Management, LP (“Axar”), and Axar Cemetery Merger Corp., a Delaware corporation and a wholly-owned subsidiary of Parent (the “Original Report”).”

Innovation1 Biotech Inc. completed a disposition involving Ingenius Biotech S.L. (closed 2022-11-07).

“On November 7, 2022, Innovation1 Biotech Inc., a Nevada corporation (the “Company”), completed the disposition (the “Disposition”) of all of the assets, including intellectual property assets, relating to Mioxal®, a nutraceutical complex composed of essential amino acids, natural coenzymes and minerals, to Ingenius Biotech S.L., a corporation organized under the laws of Spain (“Ingenius”).”

FTAI Aviation Ltd. underwent a change of control involving New FTAI (closed 2022-11-10).

“On November 10, 2022, New FTAI completed the merger and, in accordance with the Merger Agreement, Merger Sub merged with and into Old FTAI, with Old FTAI surviving the merger and becoming a wholly-owned subsidiary of New FTAI.”

FTAI Aviation Ltd. completed an acquisition involving Fortress Transportation and Infrastructure Investors LLC (Old FTAI) (closed 2022-11-10).

“On November 10, 2022, New FTAI completed the merger and, in accordance with the Merger Agreement, Merger Sub merged with and into Old FTAI, with Old FTAI surviving the merger and becoming a wholly-owned subsidiary of New FTAI.”

Axsome Therapeutics, Inc. completed an acquisition involving Jazz Pharmaceuticals plc (closed 2022-11-14).

“The final closing contemplated by the Purchase Agreement (i.e., the conveyance of the ex-U.S. assets) occurred on November 14, 2022”

Avalo Therapeutics, Inc. completed a disposition involving ES Therapeutics, LLC for $5.0 million (closed 2022-11-10).

“The transaction closed on November 10, 2022 and the Company has received the $5.0 million payment from ES.”

SUNation Energy, Inc. completed an acquisition involving Scott Maskin, James Brennan, Scott Sousa, Brian Karp for up to $22.5 million (closed 2022-11-09).

“closed contemporaneously with signing the Transaction Agreement. The Company acquired the equity of the Acquired Companies from Sellers for an aggregate purchase price of up to $22.5 million, comprised of (a) $2.5 million in cash consideration paid at closing, (b) the issuance at closing of a $5.0 million Short-Term Limited Recourse Secured Promissory Note (the”

Enliven Therapeutics, Inc. completed a disposition involving Cardurion Pharmaceuticals, Inc. for $34,750,000 upfront cash payment (closed 2022-11-10).

“On November 10, 2022, the Asset Sale was consummated and, in accordance with the Asset Purchase Agreement, Cardurion paid to Imara an upfront cash payment of $34,750,000 upon closing of the Asset Sale.”

ALR TECHNOLOGIES INC. underwent a change of control involving ALR Technologies SG Ltd. (closed 2022-11-07).

“On November 7, 2022, ALR Technologies Inc. (the “Company”) completed a merger in accordance with an Agreement and Plan of Merger and Reorganization dated May 17, 2022 (the “Merger Agreement”), by and among the Company, ALR Technologies SG Ltd., a Singapore company limited by shares (“ALR Singapore”), and its wholly-owned subsidiary, ALRT Delaware, Inc., a Delaware corporation (“ALR Delaware”), pursuant to which ALR Delaware merged with and into the Company (the “Redomicile Merger”), with the Company continuing as the surviving entity and a wholly-owned subsidiary of ALR Singapore.”

AEI NET LEASE INCOME & GROWTH FUND XX LIMITED PARTNERSHIP completed a disposition involving Mohammed Salim Ismail for net cash proceeds of approximately $340,000 (closed 2022-11-07).

“On November 7, 2022, the Partnership sold a Family Dollar store in Mobile, Alabama to Mohammed Salim Ismail, an unrelated third party. The Partnership received net cash proceeds of approximately $340,000 for the property, which resulted in a net loss of approximately $35,000.”

Pedro's List, Inc. underwent a change of control involving Eden Miller (closed 2022-10-11).

“On October 11, 2022, Eden Miller acquired control of the Company through the issuance of 37,500,000 restricted shares of common stock as described in Item 3.02 above.”

HIMALAYA TECHNOLOGIES, INC completed a disposition involving David St. James for $112,000 (closed 2022-11-07).

“On November 7, 2022, we agreed to divest our minority investment in Ranken Energy Corporation to our former CEO David St. James for $112,000.”

Neptune Wellness Solutions Inc. completed a disposition involving PurCann Pharma, Inc. for $5,150,000 (closed 2022-11-09).

“dated as of October 16, 2022, entered into with PurCann Pharma, Inc. (“Purchaser”). Pursuant to the Purchase Agreement, Purchaser paid the Company an aggregate purchase price of $5,150,000. The description above is a summary of the Purchase Agreement and the transactions contemplated thereby and is subject to, and qualified in its entirety by, reference to the full”

ARS Pharmaceuticals, Inc. underwent a change of control involving ARS Pharmaceuticals, Inc. (closed 2022-11-08).

“On November 8, 2022, Silverback, Merger Sub and ARS Pharma consummated the transactions contemplated by the Merger Agreement”

AVENUE THERAPEUTICS, INC. completed an acquisition involving Fortress Biotech, Inc. (closed 2022-11-08).

“On November 8, 2022, following the satisfaction of the closing conditions of the Contribution Agreement, the Company completed the acquisition of a majority of the outstanding shares (common and preferred) of Baergic from Fortress.”

SPX Technologies, Inc. completed a disposition involving Canvas Holdco, LLC (closed 2022-11-01).

“On November 1, 2022, the Company transferred to the Purchaser the issued and outstanding limited liability company membership interests of SPX, LLC (the “ Sale ”).”

TEAM INC completed a disposition involving Baker Hughes Holdings LLC for $279.0 million dollars (closed 2022-11-01).

“On November 1, 2022, the Company completed the sale of all of the issued and outstanding equity interests of our wholly-owned subsidiary, TQ Acquisition Inc., a Texas corporation (“TQ Acquisition”), to Baker Hughes Holdings LLC (“Baker Hughes”) for an aggregate purchase price of $279.0 million dollars, reflecting certain estimated post-closing adjustments (the “Quest Integrity Transaction”), pursuant to that certain Equity Purchase Agreement by and among us and Baker Hughes, dated as of August 14, 2022 (the “Sale Agreement”).”

OmniAb, Inc. underwent a change of control involving Ligand Pharmaceuticals Incorporated for Each share of Legacy OmniAb common stock converted into 4.90007 shares of OmniAb common stock and 0.75842 earnout shares. (closed 2022-11-01).

“upon the consummation of the Merger, each outstanding share of Legacy OmniAb Common Stock (other than treasury shares) was cancelled in exchange for the right to receive 4.90007 shares of OmniAb Common Stock and 0.75842 shares of OmniAb Common Stock subject to certain price-based earnout triggers (the “Earnout Shares”). In addition, all outstanding Legacy”

OmniAb, Inc. completed an acquisition involving Ligand Pharmaceuticals Incorporated for Each share of Legacy OmniAb common stock converted into 4.90007 shares of OmniAb common stock and 0.75842 earnout shares. (closed 2022-11-01).

“upon the consummation of the Merger, each outstanding share of Legacy OmniAb Common Stock (other than treasury shares) was cancelled in exchange for the right to receive 4.90007 shares of OmniAb Common Stock and 0.75842 shares of OmniAb Common Stock subject to certain price-based earnout triggers (the “Earnout Shares”). In addition, all outstanding Legacy”

Peak Bio, Inc. underwent a change of control involving Peak Bio Co., Ltd. (closed 2022-11-01).

“As previously disclosed, on November 1, 2022 (the “Closing Date”), Ignyte Acquisition Corp., a Delaware corporation (“Ignyte”), completed the transactions contemplated by that certain business combination agreement, dated as of April 28, 2022 (the “Business Combination Agreement”), by and among Ignyte, Ignyte Korea Co., Ltd., a corporation organized under the laws of the Republic of Korea (“Korean Sub”), and Peak Bio Co., Ltd., a corporation organized under the laws of the Republic of Korea (“Peak Bio”).”

Unity Software Inc. completed an acquisition involving ironSource Ltd. for 0.1089 shares of Unity common stock (closed 2022-11-07).

“shares, the “ ironSource ordinary shares ”), of ironSource issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive 0.1089 shares of Unity common stock (the “ Merger Consideration ”), with each fractional share rounded up or down to the nearest whole share. Unity stockholders will continue to own”

U.S. WELL SERVICES HOLDINGS, LLC underwent a change of control involving ProFrac Holding Corp. and Thunderclap Merger Sub I, Inc. for approximately $270 million (closed 2022-11-01).

“Material Relationship The value of the aggregate equity issued in connection with the Merger, based on the PFHC Common Stock 10-day VWAP as of October 31, 2022, is approximately $270 million. In addition, ProFrac is using cash to retire approximately $170 million of USWS Inc. debt, leaving approximately $35 million of various forms of equipment related financing”

Astra Energy, Inc. completed an acquisition involving HRE Scientific Holdings Ltd. for 5,000,000 shares of common stock of the Company and an agreement to license for the exclusive use of the ILPG, for the territory of California for a license fee (closed 2022-10-27).

“System In Line Power Generator (" ILPG "). Pursuant to the Agreement, HRE has agreed to sell to the Company 50 shares of common stock of Astra-Holcomb LLC in consideration of 5,000,000 shares of common stock of the Company and an agreement to license for the exclusive use of the ILPG, for the territory of California for a license fee of $5,000,000 within 30 days”

AEI INCOME & GROWTH FUND 25 LLC completed an acquisition involving AEI Income & Growth Fund 24 LLC for $1,050,000 (closed 2022-11-01).

“On November 1, 2022, the Partnership purchased an additional 50% interest in the Coliseum Health clinic in Macon, Georgia for $1,050,000 from AEI Income & Growth Fund 24 LLC, an affiliate of the Partnership.”

AEI INCOME & GROWTH FUND 24 LLC completed a disposition involving AEI Income & Growth Fund 24 LLC for net cash proceeds of approximately $1,046,000 (closed 2022-11-01).

“in Macon, Georgia to AEI Income & Growth Fund 24 LLC, an affiliate of the Company that owns an interest in the property. The Company received net cash proceeds of approximately $1,046,000 for the property, which resulted in a net gain of approximately $543,000. Section 9 – Financial Statements and Exhibits”

AVIENT CORP completed an acquisition involving DSM Protective Materials for $1.4 billion, net of cash acquired (closed 2022-09-01).

“(the “APM Acquisition”). The acquired business is referred to as Avient Protective Materials or APM. Total consideration paid by the Company to complete the APM Acquisition was $1.4 billion, net of cash acquired. In connection with the APM Acquisition, Avient i) amended its a senior secured term loan credit facility pursuant to which it issued a term loan with an”

AVIENT CORP completed a disposition involving Hilo Group Buyer, LLC (n/k/a Formerra, LLC) for $950 million in cash (closed 2022-11-01).

“company (the “Purchaser”). Pursuant to the terms of the Agreement, the Purchaser agreed to acquire the Company’s Distribution business (the “Distribution Business”) for $950 million in cash, subject to a customary working capital adjustment. On November 1, 2022, the Company completed the sale of the Distribution Business to the Purchaser pursuant to the”

LIGAND PHARMACEUTICALS INC completed a disposition involving New OmniAb, Inc. (formerly Avista Public Acquisition Corp. II) (closed 2022-11-01).

“On November 1, 2022 (the “Distribution Date”), Ligand completed the separation (the “Separation”) of its antibody discovery business and certain related assets and liabilities (the “OmniAb Business”) through a spin-off of Legacy OmniAb to Ligand’s shareholders of record as of October 26, 2022 (the “Record Date”) on a pro rata basis (the “Distribution”) and merger (the “Merger”) of Legacy OmniAb with a wholly owned subsidiary of New OmniAb in a Reverse Morris Trust transaction (collectively, the “Transactions”)”

SeaStar Medical Holding Corp underwent a change of control involving LMF Acquisition Opportunities, Inc. (LMAO) for $85,408,328 (closed 2022-10-28).

“the Business Combination was completed, which consisted of the following: The aggregate consideration payable to the stockholders of SeaStar Medical at the closing of the Business Combination (the “Closing”) was $85,408,328”

ACCESS Newswire Inc. completed an acquisition involving Lead Capital, LLC for approximately $43.9 million (closed 2022-11-01).

“through its Media Advantage Platform. Under the terms of the Purchase Agreement and on the Closing Date, the Company paid to the Seller aggregate consideration of approximately $43.9 million, consisting of the following: (i) a cash payment of $18.0 million subject to a 60-day escrow to secure the payment of any working capital adjustments or any employee bonus”

CYBEROPTICS CORP underwent a change of control involving Nordson Corporation for $54.00 per share in cash (closed 2022-11-03).

“outstanding share of common stock of CyberOptics, no par value per share (“Common Stock”), subject to certain exceptions, was automatically converted into the right to receive $54.00 in cash, without interest (the “Merger Consideration”). At the Effective Time, each stock option that was vested immediately prior to the Effective Time and each stock option that”

UPEXI, INC. completed an acquisition involving E-Core Technology, Inc. d/b/a New England Technology, Inc. for Twenty-Four Million One Hundred Thousand Dollars ($24,100,000) (closed 2022-10-31).

“the Company to the Buyer (the “Transaction”). The base consideration paid by the Buyer to the Sellers in the transaction totals Twenty-Four Million One Hundred Thousand Dollars ($24,100,000), subject to adjustment, and consists of: (i) Three Million One Hundred Thousand Dollars ($3,100,000) paid on or before the date that is thirty (30) days after the Closing Date”

Z Squared Inc. underwent a change of control involving Coeptis Therapeutics, Inc. for 17,270,079 shares of Company Common Stock issued to former Coeptis stockholders; Predecessor stockholders retained 2,246,760 shares; Coeptis warrants converted (closed 2022-10-28).

“shares of Company Common Stock at an average exercise price of $7.93 per share. On the Closing Date, the former Coeptis common stock was exchanged for the right to receive 17,270,079 shares of Company Common Stock (including 2,694,948 shares of Company Common Stock issued in exchange for the Coeptis series B preferred stock issued and outstanding). The common”

Stonemor Inc. underwent a change of control involving Axar Capital Management, LP for $3.50 in cash per share (closed 2022-11-03).

“of Common Stock held by the Company (the “ Treasury Shares ” and together with the Axar Shares, the “ Excluded Shares ”) was cancelled and converted into the right to receive $3.50 in cash per share, without interest (the “ Merger Consideration ”); • each Treasury Share was cancelled without payment of any consideration therefor; • each Axar Share was”

TEXAS CAPITAL BANCSHARES INC/TX completed a disposition involving AFCO Credit Corporation for approximately $3.4 billion (closed 2022-11-01).

“On November 1, 2022, Texas Capital Bancshares, Inc. (the “Company”), the parent company of Texas Capital Bank (the “Bank”), completed the previously announced sale of the Bank’s insurance premium finance business to AFCO Credit Corporation (“Purchaser”) pursuant to the Purchase Agreement, dated September 5, 2022, by and between the Bank and Purchaser for a purchase price of approximately $3.4 billion, which is subject to certain post-closing adjustments set forth in the Purchase Agreement.”

NEXTNAV INC. completed an acquisition involving the shareholders (the "Sellers") of Nestwave, SAS for enterprise value of $18.0 million (closed 2022-10-31).

“On October 31, 2022 (the “Closing Date”), NextNav Inc. (the “Company”) entered into a Share Transfer Agreement (the “Agreement”) with the shareholders (the “Sellers”) of Nestwave, SAS, a French société par actions simplifiée (“Nestwave”), pursuant to which the Company acquired all of the issued shares of Nestwave , for an enterprise value of $18.0 million with a gross consideration value of $19.3 million, as follows: · $4.3 million in cash, which is subject to customary adjustments in accordance with the Agreement; and · $15.0 million by issuance of 5.1 million shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), comprised of 4.0 million shares of Common Stock that were issued on the Closing Date (the “Closing Shares”) and 1.1 million Post-Closing Issued Shares (as described below).”

Redwire Corp completed an acquisition involving the Vendors for €32.0 million (closed 2022-10-31).

“Upon the closing of the Acquisition, all issued and outstanding membership Space NV Shares were transferred to the Purchaser in exchange for €32.0 million, subject to certain post-closing adjustments related to acquired cash, assumed debt and working capital adjustments.”

ProPetro Holding Corp. completed an acquisition involving New Silvertip Holdco, LLC for $150 million (closed 2022-11-01).

“of cash, the payoff of approximately $7 million of assumed debt, and certain other transaction costs, subject to customary post-closing adjustments, which implies a value of $150 million based upon a 15-day volume weighted average price ("VWAP") of ProPetro’s stock price as of October 27, 2022. The foregoing description of the Purchase Agreement is not complete”